FOLH1 and neoplasm: 68Ga-PSMA-PET/CT imaging offers precise tumor and metastasis localization, while 177Lu PSMA therapies have demonstrated significant efficacy in extending survival in metastatic PCa patients, as corroborated by numerous clinical studies (21, 22).